secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76264 grounded facts newest August 31, 2026, 5:22 PM ET RSS · JSON

Showing 3251–3300 of 18625

Appointed

Ron Gusek

Chief Executive Officer
LBRT · Liberty Energy Inc.
Filed
November 19, 2024, 6:59 PM ET
Subject to the Confirmation Condition and in accordance with the Company’s succession plan, the Board appointed William Kimble as the non-executive Chairman of the Board and Ron Gusek as the Company’s Chief Executive Officer.
Departed

John C. Lee, Jr.

President and Chief Executive Officer
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2025-02-01
Successor
Christopher F. Cosby
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, John C. Lee, Jr. gave notice of his resignation as President and Chief Executive Officer ("CEO") of Old Dominion Electric Cooperative ("ODEC"), effective February 1, 2025.
Appointed

Christopher F. Cosby

President and Chief Executive Officer
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2025-02-01
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, our board of directors appointed Christopher F. Cosby as President and CEO of ODEC, effective February 1, 2025.
Departed

Steve Richards

Chief Executive Officer
SHIM · Shimmick Corp
Effective
2024-12-02
Successor
Ural Yal
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, Steve Richards, the Company’s Chief Executive Officer (“CEO”), announced his retirement as Chief Executive Officer of the Company, effective December 2, 2024.
Appointed

Ural Yal

Chief Executive Officer
SHIM · Shimmick Corp
Effective
2024-12-02
Filed
November 18, 2024, 6:59 PM ET
the Company appointed Ural Yal as CEO, effective December 2, 2024.
Appointed (interim)

Scott Buchanan

Acting Chief Financial Officer and Principal Financial Officer
BTM · Bitcoin Depot Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
the Board has appointed Scott Buchanan, the Company’s current Chief Operating Officer (“COO”) and a member of the Board, to the role of Acting CFO and Principal Financial Officer effective as of the date of Mr. Leibowitz’s resignation, while maintaining his role as the Company's COO.
Departed

Glen Leibowitz

Chief Financial Officer
BTM · Bitcoin Depot Inc.
Effective
2024-11-15
Successor
Scott Buchanan
Filed
November 18, 2024, 6:59 PM ET
Glen Leibowitz has resigned from his role as Chief Financial Officer (“CFO”) of the Company, effective November 15, 2024, for personal reasons.
Departed

Conley Chee

President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed

Jason Haas

Chief Financial Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Appointed

Gerald Quirk

President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, the Board of Directors appointed Gerald Quirk, Esq., currently the Company’s Chief Legal & Compliance Officer and Chief Business Officer, to serve as the Company’s President and Chief Executive Officer effective as of November 22, 2024.
Departed

Gregg A. Lowe

President and Chief Executive Officer
WOLF · WOLFSPEED, INC.
Effective
2024-11-18
Filed
November 18, 2024, 6:59 PM ET
On November 18, 2024, Wolfspeed, Inc. (the “Company”) announced the departure of its President and Chief Executive Officer, Gregg A. Lowe.
Appointed

Kenneth Cook

Chief Financial Officer
WEN · Wendy's Co
Effective
2024-12-02
Filed
November 18, 2024, 6:59 PM ET
appointed Kenneth Cook as Chief Financial Officer of the Company, effective December 2, 2024
Departed

Gunther Plosch

Chief Financial Officer
WEN · Wendy's Co
Effective
2024-12-02
Successor
Kenneth Cook
Filed
November 18, 2024, 6:59 PM ET
Gunther Plosch will cease to be the Chief Financial Officer of the Company as of the Effective Date.
Appointed

Jay Giraud

CEO, President and Executive Chairman of the Board
DMNIF · Damon Inc.
Effective
2024-11-13
Filed
November 18, 2024, 6:59 PM ET
Damon Jay Giraud 48 CEO, President and Executive Chairman of the Board
Appointed

Baljinder Kaur Bhullar

CFO and Director
DMNIF · Damon Inc.
Effective
2024-11-13
Filed
November 18, 2024, 6:59 PM ET
Baljinder (Bal) Bhullar, Chief Financial Officer and Director Bal Bhullar was appointed to serve as CFO and Director of the Company with effect upon the closing of the Business Combination.
Appointed (interim)

Bonnie-Jeanne Gerety

Interim Chief Financial Officer
iLearningEngines, Inc.
Effective
2024-11-12
Filed
November 18, 2024, 6:59 PM ET
the Board appointed Bonnie-Jeanne Gerety to serve as the Company’s Interim Chief Financial Officer and principal financial officer.
Appointed

Daniel Barcelo

CEO
TE · T1 Energy Inc.
Effective
2024-11-06
Filed
November 18, 2024, 6:59 PM ET
On November 6, 2024, the Board of Directors (the “Board”) of FREYR Battery, Inc., a Delaware corporation (the “Company”), announced the appointment of Daniel Barcelo as its CEO, effective immediately.
Departed

Steven P. Rasche

Executive Vice President and Chief Financial Officer and Chief Accounting Officer
SR · SPIRE INC
Effective
2025-01-01
Successor
Adam W. Woodard
Filed
November 18, 2024, 6:59 PM ET
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Role change

Adam W. Woodard

Executive Vice President and Chief Financial Officer
SR · SPIRE INC
Effective
2025-01-01
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, the Board of Directors of Spire Inc. (the “Company”) approved the appointment of Adam W. Woodard, 53, to the position of Executive Vice President and Chief Financial Officer
Departed

Steven P. Rasche

Executive Vice President and Chief Financial Officer
SR · SPIRE INC
Effective
2025-01-01
Successor
Adam W. Woodard
Filed
November 18, 2024, 6:59 PM ET
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed

Anthony S. Chan

Chief Financial Officer
SHARING SERVICES GLOBAL Corp
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, Anthony S. Chan ceased to be employed by Sharing Services Global Corporation (the “Company”) or any of its subsidiaries.
Appointed (interim)

Adrienne Anderson

Interim Chief Financial Officer
UAVS · AgEagle Aerial Systems Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, AgEagle Aerial Systems, Inc. (the “Company”) appointed Ms. Adrienne Anderson, age 46, to the positions of Interim Chief Financial Officer and Interim Principal Accounting Officer of the Company, effective immediately
Departed

Mark DiSiena

Chief Financial Officer
UAVS · AgEagle Aerial Systems Inc.
Effective
2024-11-15
Successor
Adrienne Anderson
Filed
November 18, 2024, 6:59 PM ET
to replace Mark DiSiena who’s resignation from his position as Chief Financial Officer was effective November 15, 2024.
Role change

Louis S. Haddad

Chief Executive Officer
AHRT · AH Realty Trust, Inc.
Effective
2024-12-31
Successor
Shawn J. Tibbetts
Filed
November 18, 2024, 6:59 PM ET
Louis S. Haddad informed Armada Hoffler Properties, Inc. (the “Company”) of his decision to resign from his position as Chief Executive Officer of the Company (“Chief Executive Officer”), effective December 31, 2024.
Appointed

Shawn J. Tibbetts

Chief Executive Officer
AHRT · AH Realty Trust, Inc.
Effective
2025-01-01
Filed
November 18, 2024, 6:59 PM ET
the Board appointed Mr. Tibbetts, the Company’s President and Chief Operating Officer, to the position of Chief Executive Officer effective January 1, 2025.
Role change

Joseph M. Busky

Chief Financial Officer
QDEL · QuidelOrtho Corp
Effective
2024-11-18
Filed
November 18, 2024, 6:59 PM ET
Joseph M. Busky, the Company’s Chief Financial Officer, assuming additional responsibilities, including oversight of the Company’s Information Technology function, on November 18, 2024
Departed

Gregory S. Lovins

Senior Vice President and Chief Financial Officer
AVY · Avery Dennison Corp
Effective
2024-11-14
Successor
Danny G. Allouche
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the "Company"), began a medical leave of absence.
Appointed (interim)

Danny G. Allouche

Senior Vice President and Interim Chief Financial Officer
AVY · Avery Dennison Corp
Effective
2024-11-15
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, the Company’s Board of Directors (the “Board”) elected Danny G. Allouche as the Company’s Senior Vice President and Interim Chief Financial Officer, effective November 15, 2024.
Role change

Josh Resnik

President and Chief Executive Officer
NOTE · FiscalNote Holdings, Inc.
Effective
2025-01-01
Filed
November 15, 2024, 6:59 PM ET
On November 12, 2024, FiscalNote Holdings, Inc. (the “ Company ”) announced a leadership succession whereby Tim Hwang, the company’s current Chairman, Chief Executive Officer, and Co-founder, will transition to Executive Chairman and Josh Resnik, the company’s current President and Chief Operating Officer, will become President and Chief Executive Officer, each effective January 1, 2025.
Departed

Michael Breininger

principal financial officer and principal accounting officer
OCGN · Ocugen, Inc.
Effective
2024-11-14
Successor
Ramesh Ramachandran
Filed
November 15, 2024, 6:59 PM ET
Michael Breininger, the Company’s Corporate Controller, will no longer serve as the principal financial officer and principal accounting officer of the Company.
Appointed

Ramesh Ramachandran

principal financial officer and principal accounting officer
OCGN · Ocugen, Inc.
Effective
2024-11-14
Filed
November 15, 2024, 6:59 PM ET
the Board of Directors of Ocugen, Inc. (the “ Company ”) appointed Ramesh Ramachandran to serve as the Company’s principal financial officer and principal accounting officer
Departed (interim)

James Murphy

Interim Chief Financial Officer
MBIO · MUSTANG BIO, INC.
Effective
2024-11-12
Successor
Manuel Litchman
Filed
November 15, 2024, 6:59 PM ET
On November 12, 2024, James Murphy resigned as the Company’s Interim Chief Financial Officer.
Appointed (interim)

Manuel Litchman

Interim Chief Financial Officer
MBIO · MUSTANG BIO, INC.
Effective
2024-11-15
Filed
November 15, 2024, 6:59 PM ET
On November 15, 2024, the Company’s Board of Directors (the “Board”) appointed Manuel Litchman, M.D., President and Chief Executive Officer of the Company, as the Company’s Interim Chief Financial Officer, effective immediately.
Departed

Michael J. Grau

Executive Vice President and Chief Financial Officer
MSGE · Madison Square Garden Entertainment Corp.
Effective
2024-11-20
Successor
Lee Weinberg
Filed
November 15, 2024, 6:59 PM ET
On November 13, 2024, Madison Square Garden Entertainment Corp. (the “Company”) and Michael J. Grau, the Company’s Executive Vice President and Chief Financial Officer, agreed that he will be leaving the Company, and effective November 20, 2024, will cease to be Chief Financial Officer.
Appointed (interim)

Lee Weinberg

Interim Chief Financial Officer
MSGE · Madison Square Garden Entertainment Corp.
Effective
2024-11-20
Filed
November 15, 2024, 6:59 PM ET
Lee Weinberg will serve as the Company’s Interim Chief Financial Officer effective November 20, 2024.
Appointed

Phil Boggs

Chief Financial Officer
GPRE · Green Plains Inc.
Filed
November 15, 2024, 6:59 PM ET
On November 12, 2024, due to the appointment of Mr. Boggs as Chief Financial Officer of the Company, the Company amended the employment agreement ("Employment Agreement") dated December 2, 2021, with Mr. Boggs
Departed

Jim Stark

Chief Financial Officer
GPRE · Green Plains Inc.
Effective
2024-11-15
Successor
Phil Boggs
Filed
November 15, 2024, 6:59 PM ET
On November 15, 2024, in relation to the retirement of Jim Stark from the Chief Financial Officer role, Mr. Stark and the Company entered into a Confidential Severance Agreement and Release
Appointed (interim)

Bruce E. Thomas

interim Chief Financial Officer
FXNC · FIRST NATIONAL CORP /VA/
Effective
2024-12-02
Filed
November 15, 2024, 6:59 PM ET
The Company has appointed Bruce E. Thomas as interim Chief Financial Officer of the Company and the Bank, effective December 2, 2024.
Departed

M. Shane Bell

Executive Vice President and Chief Financial Officer
FXNC · FIRST NATIONAL CORP /VA/
Effective
2024-12-02
Successor
Bruce E. Thomas
Filed
November 15, 2024, 6:59 PM ET
On November 15, 2024, M. Shane Bell notified the Board of Directors of First National Corporation (the “Company”) and its wholly-owned subsidiary, First Bank (the “Bank”), of his resignation as Executive Vice President and Chief Financial Officer of the Company and the Bank, effective December 2, 2024.
Departed

Shawn Munsell

Chief Financial Officer
CVGW · CALAVO GROWERS INC
Effective
2024-11-29
Filed
November 15, 2024, 6:59 PM ET
On November 11, 2024, Shawn Munsell gave notice of his resignation from his position as Chief Financial Officer of Calavo Growers, Inc. (“Calavo”), effective November 29, 2024.
Role change

Patricia B. Prichep

Chief Financial and Operations Officer
CVM · CEL SCI CORP
Effective
2024-11-13
Filed
November 15, 2024, 6:59 PM ET
Patricia B. Prichep, CEL-SCI’s current senior Vice President of Operations, has assumed the duties of CEL-SCI’s Chief Financial and Operations Officer, effective November 13, 2024.
Departed

Michael Kuta

President and Chief Executive Officer
BOOM · DMC Global Inc.
Effective
2024-11-29
Successor
James O'Leary
Filed
November 14, 2024, 6:59 PM ET
On November 11, 2024, Michael Kuta notified DMC Global Inc. (the “Company”) that he will retire as the Company’s President and Chief Executive Officer and as a member of the Board of Directors (the “Board”), in each case effective as of November 29, 2024 (the “Transition Date”).
Appointed (interim)

James O'Leary

Interim President and Chief Executive Officer
BOOM · DMC Global Inc.
Effective
2024-11-29
Filed
November 14, 2024, 6:59 PM ET
On November 12, 2024, the Board appointed James O’Leary, the Company’s Executive Chairman, as the Company’s Interim President and Chief Executive Officer, effective as of the Transition Date.
Appointed

Frank Cesario

Chief Financial Officer, Vice President Finance, Treasurer and Secretary
SIGMATRON INTERNATIONAL INC
Effective
2024-11-11
Filed
November 14, 2024, 6:59 PM ET
Effective November 11, 2024, Frank Cesario was elected Chief Financial Officer, Vice President Finance, Treasurer and Secretary of the Company.
Departed

James J. Reiman

Chief Financial Officer
SIGMATRON INTERNATIONAL INC
Effective
2024-11-08
Successor
Frank Cesario
Filed
November 14, 2024, 6:59 PM ET
On November 8, 2024, the Board of Directors (the “Board”) of SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company (the “Company”), received notice that James J. Reiman, Chief Financial Officer of the Company, was resigning for personal reasons, effective November 8, 2024.
Departed

Peter Garcia

Chief Financial Officer
ALXO · ALX ONCOLOGY HOLDINGS INC
Effective
2024-11-08
Filed
November 14, 2024, 6:59 PM ET
As previously disclosed, Peter Garcia resigned as Chief Financial Officer of the Company effective November 8, 2024, due to personal reasons.
Role change

James B. Breitmeyer

Chief Executive Officer
Oncternal Therapeutics, Inc.
Effective
2024-12-02
Filed
November 14, 2024, 6:59 PM ET
In connection with the workforce reduction, James B. Breitmeyer, M.D., Ph.D. and Richard G. Vincent will transition to part-time employment status, reducing their time commitment to 50% of their current duties effective December 2, 2024.
Departed

Mahesh Karande

President and Chief Executive Officer
Omega Therapeutics, Inc.
Effective
2024-11-14
Successor
Kaan Certel
Filed
November 14, 2024, 6:59 PM ET
On November 14, 2024 (the " Transition Date "), Mahesh Karande tendered his resignation as President and Chief Executive Officer and as a member of the Board of Directors (the " Board ") of the Company, effective immediately.
Appointed

Kaan Certel

President and Chief Executive Officer
Omega Therapeutics, Inc.
Effective
2024-11-14
Filed
November 14, 2024, 6:59 PM ET
On the Transition Date, the Board appointed Kaan Certel, Ph.D., the Company’s Chief Business Officer, to serve as the Company’s President and Chief Executive Officer and elected Dr. Certel to serve as a Class I director to fill the vacancy on the Board created by Mr. Karande’s resignation, in each case, effective immediately.
Departed

Kirk Coleman

Chief Financial Officer
TFF Pharmaceuticals, Inc.
Effective
2024-11-14
Successor
Craig R. Jalbert
Filed
November 14, 2024, 6:59 PM ET
Harlan Weisman, M.D., Kirk Coleman and Zamaneh Mikhak, Ph.D., ceased serving as President/Chief Executive Officer, Chief Financial Officer and Chief Medical Officer, respectively, to be effective as of November 14, 2024.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.